Germany registered its first Corona-case on January 27, and as of April 30 around 162,500 cases have been reported, and 6.572 deaths have been registered. 123,500 people have reportedly recovered from the virus. This report intends to provide DI’s members with a selection of information on essential developments related to the Corona crisis in Germany.

The pharmaceutical industry is a key partner in Europe’s fight against disease, developing new treatments and cures for patients across Europe. It is imperative that Europe remains a competitive destination for medical research and development by maintaining, sustaining and developing a predictable, robust regulatory and innovation-supportive incentives environment.